Cas 1190219-29-4,N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide

1190219-29-4

Post Buying Request

Basic information

Product Name: N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide
Synonyms: N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide
CAS NO:1190219-29-4
Molecular Formula:
Molecular Weight: 504.055
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide(1190219-29-4)
EPA Substance Registry System: N-[5-(2-chloro-4-pyridin-3-yl-phenyl)-thiazol-2-yl]-4-(4-methylpiperazin-1-ylmethyl)-benzamide(1190219-29-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1190219-29-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1190219-29-4 Suppliers

Recommended suppliers

1190219-29-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1190219-29-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,2,1 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1190219-29:
(9*1)+(8*1)+(7*9)+(6*0)+(5*2)+(4*1)+(3*9)+(2*2)+(1*9)=134
134 % 10 = 4
So 1190219-29-4 is a valid CAS Registry Number.

1190219-29-4Upstream product

1190219-29-4Downstream Products

1190219-29-4Relevant academic research and scientific papers

Antiproliferative compounds and therapeutic uses thereof

-

Page/Page column 18-19, (2009/10/18)

Inhibitors of the oncogenic tyrosine kinase ALK and of the Bcr-Abl mutant T315I Bcr-Abl, such as a compound of formula (I): wherein Q, T, W, K, J, Y, X, Z are independently selected from C, N, S, O, provided that the corresponding rings are (hetero)aromatic; n = 0 or 1; q = 1 or 2; pharmaceutical compositions containing the same and their use for the treatment of hyper-proliferative diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1190219-29-4